Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

1.45
Delayed Data
As of 3:59pm ET
 -0.05 / -3.33%
Today’s Change
1.10
Today|||52-Week Range
3.38
-56.06%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues5.5M6.1M7.0M6.8M
 
 
 
 
 
Cost of Goods Sold4.1M3.5M3.7M3.9M
 
 
 
 
 
Depreciation And Amortization664.6K605.0K585.0K572.0K
 
 
 
 
 
 
Operating ExpensesGross Income728.6K2.0M2.7M2.3M
 
 
 
 
 
General Expenses7.1M7.1M6.7M6.3M
 
 
 
 
 
Research And Development1.2M1.5M1.7M1.6M
 
 
 
 
 
Total Operating Expenses11.9M11.3M11.0M10.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.4M-5.2M-4.0M-4.0M
 
 
 
 
 
Extraordinary Credit421.7K51.0K67.0K730.0K
 
 
 
 
 
Extraordinary Charge-890.0K--0.000.00
 
 
Pre-Tax Equity Earnings40.5K---15.0K-18.0K
 
 
 
 
Interest Expense On Debt116.9K126.0K107.0K111.0K
 
 
 
 
 
Other Expenses0.000.000.00-325.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.9M-5.3M-4.0M-3.7M
 
 
 
 
 
Income Taxes-1.2M0.000.000.00
 
 
Net Income-5.7M-5.3M-4.0M-3.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.0M13.5M14.5M16.5M
 
 
 
 
 
Shares To Calculate EPS Diluted12.0M13.5M14.5M16.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.48-$0.39-$0.28-$0.23
 
 
 
 
 
EPS Diluted-$0.48-$0.39-$0.28-$0.23